{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:39Z","timestamp":1790661099618,"version":"4.1.0"},"reference-count":13,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.2337\/dci23-0092","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:02:02Z","timestamp":1713553322000},"page":"782-784","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":35,"title":["Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?"],"prefix":"10.2337","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-5462","authenticated-orcid":false,"given":"Vala","family":"Hamidi","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-0091","authenticated-orcid":false,"given":"Jeremy H.","family":"Pettus","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"2024041919015169700_B1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2337\/dc17-1624","article-title":"Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D exchange","volume":"40","author":"Agiostratidou","year":"2017","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"key":"2024041919015169700_B5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/dia.2020.0572","article-title":"Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the International Diabetes Closed-Loop Trial","volume":"23","author":"Isganaitis","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2024041919015169700_B6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of control-IQ technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2024041919015169700_B7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B8","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2024041919015169700_B10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2024041919015169700_B11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc23-1581","article-title":"Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system","volume":"47","author":"Casta\u00f1eda","year":"2024","journal-title":"Diabetes Care"},{"key":"2024041919015169700_B12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/dia.2023.0380","article-title":"A comparison of continuous glucose monitoring-measured time-in-range 70-180\u2009mg\/dL versus time-in-tight-range 70-140\u2009mg\/dL","volume":"26","author":"Beck","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2024041919015169700_B13","article-title":"Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study","author":"Shah","journal-title":"Diabetes Technol Ther. 13 February 2024 [Epub ahead of print]."}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/5\/782\/757778\/dci230092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/5\/782\/757778\/dci230092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:02:08Z","timestamp":1713553328000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/47\/5\/782\/154500\/Time-in-Tight-Range-for-Patients-With-Type-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,19]]},"published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci23-0092","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}